News
New Evidence Links Targeted Urate-Lowering to Cardiovascular Benefits in Gout
Study links targeted urate-lowering in gout with reduced cardiovascular risk, highlighting its importance for pharmacists.
Centanafadine: First Triple Reuptake Inhibitor for ADHD Nears FDA Approval
An overview of centanafadine, a novel triple reuptake inhibitor for ADHD, covering its mechanism, clinical trials, safety, FDA status, and comparison with existing therapies.
Walmart Elevates Pharmacy Technician Roles and Pay, Benefiting Pharmacists and Students
Walmart's recent investment in pharmacy technicians enhances career opportunities and positively impacts pharmacists and pharmacy students.
UnitedHealthcare CEO Brian Thompson Fatally Shot in New York City
UnitedHealthcare CEO Brian Thompson, 50, was fatally shot in a targeted attack outside a New York City hotel on December 4, 2024. The suspect remains at large as investigations continue.
Genentech to Discontinue Fuzeon® (Enfuvirtide) Amid Evolving HIV Treatment Landscape
Genentech discontinues Fuzeon (enfuvirtide) by February 2025 as advanced HIV treatments emerge. Learn how healthcare providers should transition patients to newer therapies.
Emergent BioSolutions Enhances NARCAN® Accessibility with New Packaging and Shelf-Life Extension
Discover Emergent BioSolutions' innovations in NARCAN® Nasal Spray packaging and shelf life to boost naloxone availability and preparation.
Roche's CT-388 Achieves 22.5% Weight Loss in Phase 2 Trial
Roche's investigational obesity drug CT-388 demonstrated 22.5% placebo-adjusted weight loss at 48 weeks in Phase 2 trial, advancing to Phase 3 studies.
FDA Approves Oral Wegovy: First GLP-1 Pill for Weight Management
Explore the clinical implications of oral Wegovy (semaglutide) for chronic weight management, focusing on its pharmacology, efficacy, safety, and the pharmacist's role.